Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Prostatic Neoplasms 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Hematologic Diseases 1 Fatigue 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Bone Neoplasms 1 Bone Marrow Diseases 1

Interventions

Cyclophosphamide 3 Gemcitabine 2 regorafenib 1 liposomal doxorubicin 1 lenvatinib 1 fludarabine 1 alectinib 1 aldesleukin 1 Weight-Bearing 1 Taxes 1 Surveys and Questionnaires 1 Restraint, Physical 1 Range of Motion, Articular 1 Quality of Life 1 Proton Therapy 1 Platinum 1 Paclitaxel 1 Nivolumab 1 Metastasectomy 1 Masks 1 Lomustine 1 Irinotecan 1 Ipilimumab 1 Everolimus 1 Etoposide 1 Doxorubicin 1 Data Collection 1 Cisplatin 1 Carboplatin 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Neoplasms × Quality of Life × 90 days × Clear all

NCT05051059 2026-03-16

QOLSarcoma

Universitaire Ziekenhuizen KU Leuven

Phase NA Recruiting

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡